The treatment success rate for HIV-positive tuberculosis in Canada is projected to increase slightly from 77% in 2024 to a steady 78% from 2025 through 2028. In 2023, the actual success rate was recorded at 76%. The year-on-year improvement is initially at 1.3% from 2023 to 2024, followed by a relatively stable period with no significant changes in the subsequent years. The compound annual growth rate (CAGR) from 2024 to 2028 remains minimal, indicating steady but slow progress in treatment outcomes.
Future trends to watch for include potential advancements in medical treatments or public health initiatives that could significantly boost the success rates beyond the forecast period. Additionally, policy changes and the healthcare system's capacity to support innovations in treatment could also impact these projections.
